Genetic insight into COVID-19-related liver injury
Liver Int
.
2021 Jan;41(1):227-229.
doi: 10.1111/liv.14708.
Epub 2020 Nov 3.
Authors
Cristiana Bianco
1
,
Guido Baselli
1
,
Francesco Malvestiti
2
,
Luigi Santoro
1
,
Serena Pelusi
1
2
,
Maria Manunta
1
,
Giacomo Grasselli
2
3
,
Alessandra Bandera
2
4
,
Luigia Scudeller
5
,
Daniele Prati
1
,
Luca Valenti
1
2
Affiliations
1
Translational Medicine - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
2
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
3
Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
4
Infectious diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
5
Scientific Direction, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
PMID:
33098230
DOI:
10.1111/liv.14708
No abstract available
Keywords:
genetics; hepatitis; infectious disease; liver.
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Alanine Transaminase
COVID-19*
Humans
Liver
Liver Diseases*
SARS-CoV-2
Substances
Alanine Transaminase
Grants and funding
MC_PC_17228/MRC_/Medical Research Council/United Kingdom
MC_QA137853/MRC_/Medical Research Council/United Kingdom
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico/International